US FDA Eases Informed Consent for Minimal Risk Clinical Trials

FDA Implements 21st Century Cures Act: Effective 30 days post-publication, ensuring rights and safety of human subjects. The final rule amendment allows exceptions for informed consent in minimal-risk clinical investigations.